https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-25 / Trends Immunol. 2016 12;37(12):855-865
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-25 / Trends Immunol. 2016 12;37(12):855-8652016-10-25 00:00:002019-02-15 08:45:15Dendritic Cells and Cancer Immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-18 / Oncoimmunology 2016;5(11):e1232237
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-18 / Oncoimmunology 2016;5(11):e12322372016-10-18 00:00:002019-02-15 08:49:47Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-194
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-1942016-10-17 00:00:002016-10-17 00:00:00Immunotherapy in pancreatic cancer treatment: a new frontier
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-14 / J. Neurooncol. 2017 01;131(1):1-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-14 / J. Neurooncol. 2017 01;131(1):1-92016-10-14 00:00:002016-10-14 00:00:00Advances in immunotherapy for the treatment of glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2016-10-10 12:22:552019-02-10 12:23:30Kongress der Deutschen Gesellschaft für Hyperthermie: Kurzinformation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-10 / Stem Cell Res Ther 2016 10;7(1):149
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-10 / Stem Cell Res Ther 2016 10;7(1):1492016-10-10 00:00:002019-02-15 09:00:20Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-04 / Oncotarget 2016 Oct;7(40):65042-65051
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-04 / Oncotarget 2016 Oct;7(40):65042-650512016-10-04 00:00:002016-10-04 00:00:00Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy
